| Date | Subject |
| 10/21/2008 10:46:23 AM | |
| Alitretinoin Approved in France for Adults With Chronic Hand Eczema |
| 10/16/2008 05:34:02 PM | |
| FDA Approves Labeling Changes, Boxed Warning for Efalizumab |
| 09/25/2008 04:01:45 PM | |
| Ustekinumab Effective and Safe for Moderate to Severe Psoriasis, Regardless of Previous Treatments: Presented at EADV |
| 09/25/2008 02:38:24 PM | |
| Methyl Aminolevulinate Photodynamic Therapy an Alternative to Surgery for Superficial Basal-Cell Carcinoma: Presented at EADV |
| 09/22/2008 02:38:33 PM | |
| 5-Fluorouracil Forgiving of Poor Treatment Adherence in Actinic Keratosis: Presented at AAFP |
| 09/22/2008 01:19:54 PM | |
| Ustekinumab Shows Strong Promise for Psoriasis Patients: Presented at EADV |
| 09/22/2008 10:05:59 AM | |
| Alitretinoin Approved in Denmark for Adults With Chronic Hand Eczema |
| 09/21/2008 10:17:11 AM | |
| Efalizumab Controls Moderate-to-Severe Chronic Plaque Psoriasis of the Scalp: Presented at EADV |
| 09/21/2008 10:14:34 AM | |
| Efalizumab Well Tolerated by Patients With Moderate-to-Severe Plaque Psoriasis: Presented at EADV |
| 09/21/2008 10:03:05 AM | |
| Efalizumab Efficacious in Two-Thirds of Patients With Moderate-to-Severe Palmoplantar Psoriasis: Presented at EADV |
| 09/20/2008 09:20:02 PM | |
| Adalimumab Effective in Treating Psoriasis, Regardless of Patient Characteristics: Presented at EADV |
| 09/19/2008 12:52:13 PM | |
| Continuous Use of Adalimumab Recommended in Psoriasis Patients: Presented at EADV |
| 09/19/2008 12:31:25 PM | |
| Adalimumab Decreases C-Reactive Protein in Psoriasis Patients: Presented at EADV |
| 09/19/2008 10:33:37 AM | |
| Etanercept Provides Durable Benefit for Psychiatric Symptoms in Psoriasis Patients: Presented at EADV |
| 09/19/2008 10:31:07 AM | |
| Tacrolimus Benefits a Broad Span of Atopic Dermatitis Patients: Presented at EADV |
| 09/18/2008 04:13:00 PM | |
| Use of Paracetamol in First Year of Life Increases Risk of Asthma, Rhinoconjunctivitis, Eczema in Children |
| 09/18/2008 02:19:12 PM | |
| Ustekinumab Superior to Etanercept for Plaque Psoriasis: Presented at EADV |
| 09/18/2008 12:37:26 PM | |
| Long-Term Intermittent Tacrolimus Thwarts Flares in Paediatric Atopic Dermatitis: Presented at EADV |
| 09/15/2008 05:20:17 PM | |
| Chest X-ray Prior to Sentinel Lymph Node Biopsy May Not Be Useful in Initial Staging of Primary Melanoma: Presented at ESSO |
| 09/15/2008 05:18:36 PM | |
| FDG-PET May Detect More Bone and Skin Metastases Than Spiral CT in Melanoma Patients With Palpable Lymph Node Metastases: Presented at ESSO |
| 09/15/2008 02:47:29 PM | |
| Completion Lymph Node Dissection Might Be Avoided After Detecting a Single Sentinel Node Micrometastasis in Cutaneous Melanoma: Presented at ESSO |
| 09/15/2008 02:45:40 PM | |
| Isolated Limb Infusion a Safe and Effective Way to Deliver Chemotherapy in Elderly Patients With Advanced Metastatic Melanoma of the Limb: Presented at ESSO |
| 09/14/2008 05:35:41 PM | |
| No Benefit for Extended-Schedule Temozolomide in Treating Advanced Melanoma: Presented at ESMO |
| 09/02/2008 05:12:28 PM | |
| Health Canada Approves Ceftobiprole Medocaril for Treatment of Complicated Skin Structure Infections |
| 08/20/2008 03:04:49 PM | |
| Calcipotriene, Betamethasone Dipropionate Gel Approved in Europe for Scalp Psoriasis |
| 08/12/2008 01:14:19 PM | |
| FDA Issues Warning for Naltrexone Injection Site Reactions |
| 08/07/2008 04:19:32 PM | |
| HIV Patients With Injection-Site Reactions Switched From Enfuvirtide to Raltegravir: Presented at AIDS 2008 |
| 07/10/2008 06:30:21 PM | |
| Pegylated Interferon Alfa-2b Improves Recurrence-Free Survival in Patients With Melanoma |
| 07/08/2008 02:14:45 PM | |
| European Commission Approves Once-Weekly Etanercept for Psoriasis |
| 07/07/2008 02:12:20 PM | |
| Aggressive Treatment of Childhood Eczema Could Help Prevent Asthma |
| 06/30/2008 02:06:54 PM | |
| Ceftobiprole Approved in Canada for Treatment of Complicated Skin Infections |
| 06/25/2008 01:03:25 PM | |
| NICE Issues New Guidelines for Adalimumab in Adult Psoriasis |
| 06/14/2008 02:08:14 PM | |
| Malignancies in Etanercept-Treated Patients Uncommon: Presented at EULAR |
| 06/07/2008 06:52:24 AM | |
| US FDA Announces New Labelling Changes for Becaplermin |
| 06/06/2008 03:28:34 PM | |
| Progression-Free Survival Improved in Melanoma Patients Treated With Elesclomol: Presented at ASCO |
| 06/05/2008 05:00:50 PM | |
| Sargramostim Appears to Achieve Long-Term Survival in Patients With High-Risk Malignant Melanoma: Presented at ASCO |
| 06/05/2008 10:24:41 AM | |
| Response to Investigational Ipilimumab Observed Among Patients With Advanced Melanoma: Presented at ASCO |
| 06/04/2008 05:50:32 PM | |
| Increased Incidence of Melanoma in Rheumatoid Arthritis Patients Treated With Methotrexate |
| 05/20/2008 09:50:23 AM | |
| Delayed Adverse Effects May Occur Following Injection With Cosmetic Skin Fillers |
| 05/15/2008 09:55:19 AM | |
| Ustekinumab Is Effective at Treating Psoriasis in Most Patients |
| 05/07/2008 10:49:30 AM | |
| Low-Dose, Drospirenone-Containing Oral Contraceptive Approved in Europe |
| 04/25/2008 11:27:02 AM | |
| Linezolid Shows Efficacy for Complicated Skin and Soft-Tissue Infections: Presented at ECCMID |
| 04/22/2008 05:08:23 PM | |
| Iclaprim Eradicates Complicated Skin and Skin Structure Infections: Presented at ECCMID |
| 03/27/2008 04:30:37 PM | |
| Becaplermin May Increase Risk of Death From Cancer in Patients With Diabetes |
| 03/24/2008 09:33:32 AM | |
| As Use of Biologicals Rises, So Too Will Cutaneous Reactions to Them: Presented at AAAAI |
| 03/20/2008 09:12:49 AM | |
| Sentinel Node Number Predicts 5-Year Melanoma Survival in Database Analysis: Presented at SSO |
| 03/20/2008 09:06:57 AM | |
| FDA Approves New Medical Adhesive to Treat Burn Patients |
| 03/17/2008 10:23:22 AM | |
| Etanercept PI Gets Boxed Warning for Risk of Infections, Tuberculosis |
| 02/28/2008 02:59:15 PM | |
| FDA Approves Rilonacept for the Treatment of Rare Inflammatory Syndromes |
| 02/19/2008 02:23:10 PM | |
| FDA Approves Xyzal (Levocetirizine Dihydrochloride) Oral Solution for Allergic Rhinitis and Chronic Idiopathic Urticaria |
| 02/11/2008 09:17:00 AM | |
| Combination Terbinafine/Ciclopirox Effective for Toenail Dermatophyte Onychomycosis: Presented at AAD |
| 02/08/2008 06:02:38 PM | |
| Patch Testing Effective for Paediatric Allergic Contact Dermatitis: Presented at AAD |
| 02/08/2008 06:00:46 PM | |
| Combination Topical Therapy Effective And Safe for Moderate and Moderate-Severe Acne: Presented at AAD |
| 02/07/2008 11:25:16 AM | |
| Investigative Pramiconazole Effective for Treating Pityriasis Versicolor: Presented at AAD |
| 02/07/2008 11:23:17 AM | |
| Ketoconazole 2% Foam Effective and Safe for Seborrheic Dermatitis: Presented at AAD |
| 02/07/2008 08:48:42 AM | |
| Bexarotene 1% Gel Shows Efficacy for Alopecia Areata: Presented at AAD |
| 02/06/2008 02:00:49 PM | |
| Etanercept Shows High Efficacy and Tolerability for Pediatric Psoriasis: Presented at AAD |
| 02/04/2008 05:25:58 PM | |
| Methotrexate Effective and Safe for Children With Severe Atopic Dermatitis: Presented at AAD |
| 02/04/2008 02:33:18 PM | |
| Investigative Apremilast Shows Efficacy and Safety for Treatment of Plaque Psoriasis: Presented at AAD |
| 02/04/2008 12:47:27 PM | |
| Organ Transplant Patients Largely Unaware of Increased Skin Cancer Risk: Presented at AAD |
| 02/04/2008 11:56:53 AM | |
| Infliximab (Remicade) Treated Plaque Psoriasis Patients Show Consistently High Clearance in Critical Body Regions: Presented at AAD |
| 02/04/2008 09:04:02 AM | |
| Ustekinumab Shows Long-Term Efficacy for Chronic Plaque Psoriasis: Presented at AAD |
| 01/21/2008 10:18:47 AM | |
| Humira (adalimumab) Receives FDA Approval for Moderate to Severe Chronic Plaque Psoriasis |
| 12/20/2007 02:23:04 PM | |
| Abbott's HUMIRA® Approved in the European Union for Treatment of Moderate-to-Severe Plaque Psoriasis |
| 12/12/2007 12:28:11 PM | |
| Carbamazepine Prescribing Information to Include Recommendation of Genetic Test for Patients with Asian Ancestry |
| 11/13/2007 10:49:35 AM | |
| Experimental Biologic Ustekinumab Produces Substantial Responses in Psoriatic Arthritis: Presented at ACR |
| 11/12/2007 04:41:51 PM | |
| Golimumab Significantly Improves Joint, Skin, and Nail Manifestations of Psoriatic Arthritis: Presented at ACR |
| 11/06/2007 09:01:18 AM | |
| Is NGR-TNF Effective in Patients with Refractory Solid Tumours? Presented at AACR-NCI-EORTC |
| 11/02/2007 01:14:32 PM | |
| Investigational Kinase Inhibitor Continues to Show Efficacy in Patients with Solid Tumours: Presented at AACR-NCI-EORTC |
| 11/02/2007 08:23:48 AM | |
| Radiation Plus Wide Excision Improves Survival in Patients with Merkel Cell Carcinoma: Presented at ASTRO |
| 11/01/2007 10:14:47 AM | |
| Foot and Mouth, Blue Tongue... New Disease Plagues U.K. Farmers |
| 11/01/2007 09:33:54 AM | |
| A New Monoclonal Antibody, VEGF Inhibitor Is Active in Patients with Advanced Solid Tumours: Presented at AACR-NCI-EORTC |
| 10/30/2007 03:47:29 PM | |
| Women With Breast Cancer Have Less Dermatitis When Treated With IMRT |
| 10/29/2007 10:35:27 AM | |
| Study Shows Smoking Increases Risk of Psoriasis |
| 10/18/2007 10:29:32 AM | |
| Prebiotics, Probiotics Could Protect Some Infants From Eczema |
| 10/11/2007 10:34:55 AM | |
| Treatment of Mild to Moderate Acne: Presented at AAFP |
| 10/10/2007 09:42:49 AM | |
| Oral Linezolid Cost Effective Versus Intravenous Vancomycin: Presented at IDSA |
| 10/01/2007 12:57:39 PM | |
| Higher Death Rates in Kidney Patients With Newly Recognized Disease |
| 09/27/2007 11:35:50 AM | |
| Less Invasive Lymph Node Biopsy Method Could Spare Thousands Unnecessary Operations |
| 09/24/2007 03:21:03 PM | |
| New Study Suggests Cause of Debilitating Skin Condition |
| 09/18/2007 09:00:13 AM | |
| Skin Cooling Associated With Increased Risk of Discoloration After Laser Treatment |
| 09/13/2007 03:08:27 PM | |
| Children With Allergies Potentially Over-Prescribed Steroids |
| 09/13/2007 02:57:01 PM | |
| New Technology Set to Improve Skin Cancer Treatment |
| 09/12/2007 08:21:02 AM | |
| Breastfeeding Does Not Protect Children Against Developing Asthma or Allergies |
| 08/29/2007 12:15:18 PM | |
| Biologic Treatment for Rheumatoid Arthritis Associated With Increased Risk for Skin Cancers, But Not Other Cancers |
| 08/20/2007 05:31:49 PM | |
| Increased Distance to Physician Associated with Thicker Skin Cancer at Diagnosis |
| 08/13/2007 06:15:21 PM | |
| Reports of Progressive Multifocal Leukoencephalopathy Following Rituxan Use in Systemic Lupus Erythematosus and Vasculitis (Off-label Use) |
| 08/06/2007 05:17:37 PM | |
| Researchers Discover Cause of Rosacea |
| 08/02/2007 03:03:29 PM | |
| Efalizumab Effective in Treatment of Heavy Psoriasis Patients |
| 07/06/2007 05:47:42 PM | |
| Narrow-Band UVB Treatment of Vitiligo Leads to High Levels of Patient, Physician Satisfaction: Presented at CDA |
| 07/06/2007 05:14:16 PM | |
| Superficial Infantile Haemangiomas Respond Well to Topical Antiproliferative Cream: Presented at CDA |
| 07/04/2007 10:37:13 AM | |
| Switch From One to Another Biological May Prove Effective When Response to First Is Inadequate: Presented at CDA |
| 07/03/2007 03:16:20 PM | |
| Skin Rash Actually Signifies Better Outcomes for Pancreatic and Lung Cancer Patients |
| 07/03/2007 02:40:32 PM | |
| Disease Control More Effective, Rapid With Two-Compound Gel for Scalp Psoriasis: Presented at CDA |
| 07/03/2007 02:32:00 PM | |
| New Pediculicide Proves Superior to Others in Head-to-Head Comparisons: Presented at CDA |
| 07/03/2007 12:50:50 PM | |
| Narrow-Band UVB Home Units Prove Popular With Patients: Presented at CDA |
| 07/03/2007 12:46:12 PM | |
| New Calcineurin Inhibitor Not Associated With Renal Function Decline in Psoriatic Patients: Presented at CDA |
| 07/03/2007 12:41:20 PM | |
| Topical Antiseptic Improves Chronic Nonhealing Wounds: Presented at CDA |
| 06/19/2007 03:35:30 PM | |
| Long-term Etanercept Reduces Psoriasis Severity Without Increased Adverse Events |
| 06/12/2007 09:37:38 AM | |
| Combination Improves Survival of Metastatic Melanoma Patients: Presented at ASCO |
| 06/11/2007 09:59:03 AM | |
